Matthew C Baker (Matthew Baker)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 13

Top Topics

Rheumatoid Arthritis

St Segment Elevation Myocardial Infarction

Top Venues

Arthritis & rheumatology (Hoboken, N.J.)

Rheumatology advances in practice

The Journal of rheumatology

This page only lists publications with an associated author ORCID identifier.

Publications

Zachary S Wallace, Guy Katz, Yasmin G Hernandez-Barco, Matthew C Baker
Current and future advances in practice: IgG4-related disease. Rheumatology advances in practice 8 (2) (2024)
Zachary S Wallace, Guy Katz, Yasmin G Hernandez-Barco, Matthew C Baker
Current and future advances in practice: IgG4-related disease. Rheumatology advances in practice 8 (2) (2024)
Zachary S Wallace, Guy Katz, Yasmin G Hernandez-Barco, Matthew C Baker
Current and future advances in practice: IgG4-related disease. Rheumatology advances in practice 8 (2) (2024)
Matthew C Baker, Sarah Kavanagh, Stanley B Cohen, Alan K Matsumoto, Ara Dikranian, John Tesser, Alan Kivitz, Konstantinos Alataris, Mark C Genovese
A Randomized, Double-Blind, Sham-Controlled, Clinical Trial of Auricular Vagus Nerve Stimulation for the Treatment of Active Rheumatoid Arthritis. Arthritis & rheumatology (Hoboken, N.J.) (2023)
Matthew C Baker, Khushboo Sheth, Rong Lu, Di Lu, Ericka P von Kaeppler, Archana Bhat, David T Felson, William H Robinson
Increased risk of osteoarthritis in patients with atopic disease. Annals of the rheumatic diseases (2023)
Matthew C Baker, Audra Horomanski, Yiwen Wang, Liu Yuhan, Shima Parsafar, Robert Fairchild, Joshua J Mooney, Rishi Raj, Ronald Witteles, Mark C Genovese
A double-blind, placebo-controlled, randomized withdrawal trial of sarilumab for the treatment of glucocorticoid-dependent sarcoidosis. Rheumatology (Oxford, England) (2023)
Julia F Simard, Rong Lu, Titilola O Falasinnu, Matthew C Baker, Saadiya Hawa, Mariani D Deluna, Audra Horomanski, Robert M Fairchild
Biologics Initiation in Rheumatoid Arthritis by Race and Ethnicity: Results From a Randomized Survey Study. ACR open rheumatology (2023)
Matthew C Baker, Konstantinos Alataris, Mark C Genovese
Reply. Arthritis & rheumatology (Hoboken, N.J.) (2023)
Marie Humbert-Droz, Zara Izadi, Gabriela Schmajuk, Milena A Gianfrancesco, Matthew C Baker, Rebecca Grainger, Suzanne Tamang
Development of a Natural Language Processing System for Extracting Rheumatoid Arthritis Outcomes From Clinical Notes Using the National Rheumatology Informatics System for Effectiveness Registry. Arthritis care & research (2022)
Wilson Kuswanto, Matthew C Baker
The Third Dose Is the Charm: Effective Cellular and Humoral Immune Responses to Third COVID-19 Vaccine Doses in Immunosuppressed Nonresponders. The Journal of rheumatology 49 (12) (2022)
Matthew C Baker, Vamsee Mallajosyula, Mark M Davis, Scott D Boyd, Kari C Nadeau, William H Robinson
Effective Viral Vector SARS-CoV-2 Booster Vaccination in a Patient with Rheumatoid Arthritis after Initial Ineffective mRNA Vaccine Response. Arthritis & rheumatology (Hoboken, N.J.) (2021)
Matthew C Baker, Yashaar Chaichian, Mark Genovese, Vimal K Derebail, Panduranga Rao, Winn Chatham, Michael Bubb, Sam Lim, Hooman Hajian, Oksana Gurtovaya, Uptal Patel, James Tumlin
Phase II, randomised, double-blind, multicentre study evaluating the safety and efficacy of filgotinib and lanraplenib in patients with lupus membranous nephropathy. RMD open 6 (3) (2021)
Matthew C Baker, Yingjie Weng, William H Robinson, Neera Ahuja, Nidhi Rohatgi
Reduction in Osteoarthritis Risk After Treatment With Ticagrelor Compared to Clopidogrel: A Propensity Score-Matching Analysis. Arthritis & rheumatology (Hoboken, N.J.) 72 (11) (2020)